New Post Public Reply Private Reply Replies (0) Message Board Keep ← Newer Older → whytestocks Nov 13, 2023 at 12:30 PM 106 $MBRX News Article - Penny Stock Moleculin Highlights Interim Data From Blood Cancer Study With Complete Response Rate of 38% | Benzinga https://marketwirenews.com/news-releases/penn...54813.html My Twitter: WhyteStocks Newer Older
